Menu
Medical Condition
Emergency Medicine & Trauma
Emergency Medicine & Trauma ICD-10: E27.1_1

Addison's Disease

Primary adrenal insufficiency leading to deficient cortisol and aldosterone production.

Medical Disclaimer
This condition guide is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding any symptoms or medical conditions.

Clinical Assessment & Protocol

Typical Presentation (HPI)

Fatigue, weight loss, salt craving, and hyperpigmentation of skin.

General Examination

Hypotension, hyperpigmentation in palmar creases and oral mucosa.

Treatment Protocol

Replacement of glucocorticoids and mineralocorticoids.

Patient Education

Must carry emergency steroid injection kit for adrenal crisis prevention.

Systemic & Specialized Examinations

Cardiovascular

EN: S1, S2 present. No murmurs. AR: صوتا القلب الأول والثاني طبيعيان. لا توجد نفخات.

Respiratory

EN: Lungs clear to auscultation. AR: الرئتان صافيتان عند التسمع.

Gastrointestinal

EN: Abdomen soft, non-tender. AR: البطن لين ولا يوجد ألم.

Neurological

EN: Alert, oriented x3. No focal deficits. AR: المريض واعي ومدرك. لا يوجد عجز عصبي بؤري.

Dermatological

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Psychiatric

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

OB/GYN

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Ophthalmic

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Dental

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Comprehensive Clinical Guide: Addison’s Disease (Primary Adrenal Insufficiency)

1. Introduction & Overview

Addison’s disease, clinically classified as Primary Adrenal Insufficiency (PAI), is a rare, chronic endocrine disorder occurring when the adrenal glands fail to produce sufficient amounts of steroid hormones, specifically cortisol and, frequently, aldosterone. Unlike secondary adrenal insufficiency, which originates from pituitary dysfunction, Addison’s disease is characterized by the direct destruction or dysfunction of the adrenal cortex.

The clinical significance of Addison’s disease lies in its potential for life-threatening complications, primarily the "Adrenal Crisis." Due to the non-specific nature of early symptoms, diagnosis is often delayed, leading to significant morbidity. This guide serves as an authoritative resource for clinical practitioners, detailing the pathophysiology, diagnostic pathways, and long-term management strategies required to stabilize and support patients with this condition.


2. Pathophysiology and Etiology

The Mechanisms of Hormonal Deficiency

The adrenal cortex is divided into three zones: the zona glomerulosa (aldosterone), the zona fasciculata (cortisol), and the zona reticularis (androgens). In Addison’s disease, at least 90% of the adrenal cortex must be destroyed before clinical symptoms manifest.

  • Cortisol Deficiency: Leads to impaired glucose metabolism, reduced vascular tone, and an inability to handle physiological stress.
  • Aldosterone Deficiency: Results in renal sodium wasting, potassium retention (hyperkalemia), and subsequent hypovolemia/hypotension.
  • Androgen Deficiency: Primarily affects women, leading to loss of axillary/pubic hair and decreased libido.

Etiological Classifications

The destruction of the adrenal cortex can be categorized by the underlying mechanism:

Etiology Mechanism
Autoimmune Adrenalitis Most common in developed nations (70-80%); associated with 21-hydroxylase antibodies.
Infectious Tuberculosis remains the most common cause globally; also HIV/AIDS, fungal infections (histoplasmosis).
Hemorrhagic Bilateral adrenal infarction or hemorrhage (Waterhouse-Friderichsen syndrome).
Metastatic Bilateral infiltration by lung, breast, or renal cell carcinoma.
Genetic/Congenital Congenital Adrenal Hyperplasia (CAH), Adrenoleukodystrophy (ALD).

3. Clinical Presentation and Staging

Standard Clinical Indications

Early symptoms are notoriously vague, often masquerading as depression or chronic fatigue syndrome. Clinicians should maintain a high index of suspicion in patients presenting with:

  1. Hyperpigmentation: Specifically in palmar creases, buccal mucosa, and pressure points (caused by elevated ACTH and MSH).
  2. Gastrointestinal Distress: Chronic nausea, vomiting, abdominal pain, and weight loss.
  3. Hemodynamic Instability: Orthostatic hypotension and dizziness.
  4. Musculoskeletal: Myalgias and arthralgias.
  5. Salt Craving: A hallmark symptom due to profound hyponatremia.

The Adrenal Crisis: A Medical Emergency

An adrenal crisis is an acute exacerbation of the deficiency, often triggered by surgery, trauma, or severe infection.
* Clinical Signs: Severe hypotension (refractory to vasopressors), shock, fever, altered mental status, and severe abdominal pain.
* Management: Immediate IV hydrocortisone (100mg bolus), aggressive fluid resuscitation (0.9% Normal Saline), and electrolyte correction.


4. Diagnostic Pathways

Key Diagnostic Tests

The gold standard for diagnosis is the ACTH Stimulation Test.

Test Clinical Utility
Serum Cortisol (8 AM) Screening tool; values < 3 mcg/dL are highly suggestive.
Plasma ACTH High in PAI (due to lack of negative feedback); low in Secondary AI.
ACTH Stimulation (Cosyntropin) Failure to increase cortisol > 18 mcg/dL confirms adrenal insufficiency.
21-Hydroxylase Antibodies Confirms autoimmune etiology.
Electrolytes Hyponatremia and hyperkalemia are classic markers.

Differential Diagnosis

Clinicians must differentiate Addison’s from conditions with overlapping symptoms:
* Secondary Adrenal Insufficiency: Check ACTH levels; hyperpigmentation is absent.
* Gastroenteritis/IBS: Differentiated by electrolyte abnormalities and lack of response to rehydration.
* Chronic Fatigue Syndrome: Lacks the objective biochemical markers of adrenal failure.
* Hypothyroidism: Often comorbid (Schmidt’s Syndrome), but requires TSH/T4 testing.


5. Long-term Management and Prognosis

Pharmacological Replacement Therapy

Treatment is lifelong and requires a combination of glucocorticoids and mineralocorticoids.

  • Glucocorticoids: Hydrocortisone (15–25 mg daily in divided doses) or Prednisone (3–5 mg daily).
  • Mineralocorticoids: Fludrocortisone (0.05–0.2 mg daily).
  • DHEA Replacement: Optional, primarily for patients suffering from persistent mood or libido issues.

"Sick Day" Rules

Patients must be educated on adjusting dosages during illness:
1. Minor illness: Double the daily glucocorticoid dose.
2. Severe illness/Fever: Triple the dose or seek emergency parenteral administration.
3. Medical ID: Patients MUST wear a medical alert bracelet at all times.

Prognosis

With proper medication adherence and patient education, the life expectancy for a patient with Addison’s disease is near-normal. The primary mortality risk remains the Adrenal Crisis; therefore, psychological support and thorough patient education on "stress dosing" are paramount for long-term survival.


6. Risks, Side Effects, and Contraindications

  • Over-replacement Risks: Cushingoid features, osteoporosis, hypertension, and psychiatric manifestations.
  • Under-replacement Risks: Chronic fatigue, weight loss, and the ever-present threat of adrenal crisis.
  • Contraindications: Avoid abrupt cessation of steroids. Caution with drugs that induce hepatic enzymes (e.g., rifampin, phenytoin), as they increase the clearance of cortisol, necessitating higher replacement doses.

7. Frequently Asked Questions (FAQ)

1. Is Addison’s disease the same as Cushing’s disease?
No. They are diametrically opposed. Addison’s is a lack of cortisol, while Cushing’s is an excess of cortisol.

2. Can I live a normal life with Addison’s?
Yes. With consistent medication and stress-dose adjustments, individuals lead active, productive lives.

3. What is the most common cause of Addison’s in the US?
Autoimmune adrenalitis is the leading cause in developed nations.

4. Why is my skin turning darker?
The pituitary gland produces excess ACTH to stimulate the adrenal glands. ACTH shares a precursor with Melanocyte-Stimulating Hormone (MSH), which causes skin darkening.

5. How do I know if I am having an adrenal crisis?
Symptoms include sudden severe pain in the lower back or abdomen, vomiting, diarrhea, and loss of consciousness. It is a medical emergency.

6. Do I need to take salt supplements?
Often, yes. Patients with mineralocorticoid deficiency require adequate sodium intake to maintain blood pressure.

7. Can I participate in high-intensity sports?
Yes, but you must monitor hydration and adjust glucocorticoid doses if the activity is extremely strenuous or prolonged.

8. Is there a cure?
Currently, there is no cure, only replacement therapy. Research into regenerative medicine and stem cells is ongoing.

9. Are my children at risk?
If the cause is autoimmune, there is a slightly higher genetic predisposition, but it is not inherited in a simple Mendelian fashion.

10. What happens if I forget a dose?
Missing a single dose may cause fatigue or malaise, but skipping multiple doses can trigger an adrenal crisis. Consistency is critical.


8. Clinical Summary for Healthcare Providers

Addison’s disease remains a clinical challenge due to its insidious onset. The primary goal of the physician is the avoidance of adrenal crisis through patient empowerment. Every patient should have a "Crisis Kit" consisting of injectable hydrocortisone and a clear written plan for emergency administration. Routine monitoring of electrolytes and annual assessments of bone density and cardiovascular health are recommended for all stable patients.

By maintaining a high index of suspicion and ensuring rigorous patient education, the clinical team can mitigate the risks associated with this complex endocrine deficiency, ensuring the patient maintains a high quality of life despite the diagnosis.

Treatment & Management Options

Share this guide: